Stay updated with breaking news from Pharma Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's closing price. Strides Pharma Science shares also hit their 52-week high of Rs 539.
PT Kalbe Farma Tbk and PT Amarox Global Pharma announced that they have begun marketing Movfor (Molnupiravir), the newest antiviral drug for COVID-19, in ...
Amarox is expected to kick off the domestic production of Molnupiravir in April or May 2022.
Indonesia is targeting to start local production of two COVID-19 antiviral pills, Molnupiravir and Paxlovid, in April or May this year...
Thailand's health minister said on Friday night (Jan 14) the country planned to develop the antiviral pill molnupiravir to combat Covid-19 cases amid rising infections driven by the Omicron variant.